Guardant Health (GH) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -96.2% | -136.8% | -76.8% | -52.8% | -38.1% | -36.2% | ||
| Changes by years, y/y, % | -18pp | -41pp | +60pp | +24pp | +15pp | -13.5% | |||
Guardant Health. EBITDA margin, %
Guardant Health. EBITDA margin, changes, pp
Guardant Health (GH) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -41.2% | -38.3% | -31.0% | -42.3% | -33.5% | -36.2% | |
| Changes by years, y/y, % | +20pp | +13pp | +19pp | +7pp | +8pp | |||
| Changes by quarters, q/q, % | +8pp | +3pp | +7pp | -11pp | +9pp | |||